AKT1 and cancer: Consistent with previous reports on the tumor suppressor function of PHLPP in other cancer types [13, 15–18], our results here provide the initial evidence that PHLPP is capable of inhibiting both Akt and MEK/ERK signaling in pancreatic cancer cells.